Work

Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.10553

Authors: Brian H. Kushner, Shakeel Modak, Michael P LaQuaglia, Suzanne L. Wolden, Ellen M. Basu, Stephen S. Roberts, Kim Kramer, Irene Y. Cheung, Nai-Kong V. Cheung

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891671848

Cites:

Cited by: 1

Related to: 10